Chris Cargill - Sosei Group President, Officer
| SOLTF Stock | USD 8.05 0.00 0.00% |
Insider
Chris Cargill is President, Officer of Sosei Group
| Age | 39 |
| Phone | 81 3 5210 3290 |
| Web | https://soseiheptares.com |
Sosei Group Management Efficiency
The company has return on total asset (ROA) of 0.0714 % which means that it generated a profit of $0.0714 on every $100 spent on assets. This is way below average. Sosei Group's management efficiency ratios could be used to measure how well Sosei Group manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| JD Howton | Solid Biosciences LLC | 52 | |
| Joanne CPA | Biovie Inc | 69 | |
| Jessie MBA | Rocket Pharmaceuticals | N/A | |
| Brian Sullivan | Elevation Oncology | N/A | |
| Jenna Cohen | Blueprint Medicines Corp | N/A | |
| Steven Almo | Cue Biopharma | 63 | |
| Joseph Shulman | Rhythm Pharmaceuticals | 48 | |
| Pamela Cramer | Rhythm Pharmaceuticals | 49 | |
| TaiWei Ho | In8bio Inc | 47 | |
| Tracey Esq | Blueprint Medicines Corp | 56 | |
| Manolo Bellotto | Gain Therapeutics | 53 | |
| Salvatore Calabrese | Gain Therapeutics | 54 | |
| Annie Neild | NewAmsterdam Pharma | N/A | |
| Alexander Kuta | Uniqure NV | 64 | |
| Hunter MBA | Rhythm Pharmaceuticals | 55 | |
| MBA JD | Apellis Pharmaceuticals | 51 | |
| Lawrence Lamb | In8bio Inc | 69 | |
| Jaa Roberson | Day One Biopharmaceuticals | N/A | |
| Launa Aspeslet | Hepion Pharmaceuticals | N/A | |
| Todd MD | Hepion Pharmaceuticals | 55 | |
| Alexis AM | Blueprint Medicines Corp | 52 | |
Management Performance
| Return On Equity | -0.007 | |||
| Return On Asset | 0.0714 |
Sosei Group Leadership Team
Elected by the shareholders, the Sosei Group's board of directors comprises two types of representatives: Sosei Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sosei. The board's role is to monitor Sosei Group's management team and ensure that shareholders' interests are well served. Sosei Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sosei Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Candelle Chong, VP Communications | ||
| Chris Cargill, President, Officer | ||
| Stacey Southall, Associate Biophysics | ||
| Shinichiro Nishishita, VP Disclosures | ||
| Shinichi Tamura, CEO and President Representative Executive Officer, Director and Member of Nomination Committee | ||
| Kieran FCA, VP Officer | ||
| Miles Congreve, Chief Officer | ||
| Kazuhiko Yoshizumi, VP Officer | ||
| Hironoshin Nomura, VP Relations | ||
| Barry Kenny, Chief Devel |
Sosei Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Sosei Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.007 | |||
| Return On Asset | 0.0714 | |||
| Profit Margin | (0.02) % | |||
| Operating Margin | 0.46 % | |||
| Current Valuation | 958.29 M | |||
| Shares Outstanding | 81.92 M | |||
| Shares Owned By Insiders | 12.05 % | |||
| Shares Owned By Institutions | 26.29 % | |||
| Price To Earning | 66.82 X | |||
| Price To Book | 2.36 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Sosei Pink Sheet
Sosei Group financial ratios help investors to determine whether Sosei Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sosei with respect to the benefits of owning Sosei Group security.